Blood Cancer Video Library - Brody - Chronic Lymphocytic Leukemia (CLL) - New BTK Inhibitors

Article and Video CATEGORIES

Cancer Journey

ABOUT

ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology Cancer (Oncology), Hematology-Oncology, The Mount Sinai Hospital

Blood Cancer Video Library - Brody - Chronic Lymphocytic Leukemia (CLL) - New BTK Inhibitors

dbrock

Tue, 05/12/2020 - 19:27

Author

Joshua Brody, MD

Click to Download Transcript

We are happy to bring you updates to the GRACE Blood Cancer Video Library.

For the GRACE Blood Cancer Video Library, Dr. Joshua Brody, Assistant Professor of Medicine, Hematology and Medical Oncology and Director of the Lymphoma Immunotherapy Program at the Icahn School of Medicine at Mount Sinai Hospital joins us to discuss updates from ASH 2019.

For this video, Dr. Brody shares information on CLL (Chronic Lymphocytic Leukemia) and a new generation of BTK Inhibitors

Lets have a conversation - visit https://cancergrace.org/forum.

Video Language

English

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

Next Previous link

Previous Post Next Post

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.